The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I-III platform study evaluating the safety and efficacy of multiple therapies in patients with biomarker-defined locally advanced, unresectable stage III non–small-cell lung cancer (NSCLC).
 
Luis G. Paz-Ares
Leadership - ALTUM Sequencing; Genomica
Honoraria - Amgen; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Janssen; Lilly; Medscape; Merck Serono; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Regeneron; Roche/Genentech; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); Kura Oncology (Inst); MSD (Inst); Pfizer (Inst); PharmaMar (Inst)
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Carl Michael Gay
Honoraria - Aptitude Health; OncLive/MJH Life Sciences; Peerview
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; G1 Therapeutics; Jazz Pharmaceuticals; KisoJi Biotechnology; Monte Rosa Therapeutics; Pharmerit
Speakers' Bureau - AstraZeneca; BeiGene
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - Patent pending related to small cell lung cancer transcriptional subtypes.
Travel, Accommodations, Expenses - Dava Oncology; ESMO
 
Caicun Zhou
Honoraria - Amoy Diagnostics; Anheart Therapeutics; Boehringer Ingelheim; C-Stone LUYE Pharma; Hengrui Pharmaceutical ; Innovent Biologics; Lilly O.; MSD; QiLu Pharmaceutical; Roche; Sanofi; TopAlliance Biosciences Inc
Consulting or Advisory Role - Hengrui Pharmaceutical ; Innovent Biologics; TopAlliance Biosciences Inc
 
Terufumi Kato
Employment - Lilly (I)
Honoraria - Amgen; AstraZeneca; BeiGene; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; GlaxoSmithKline; Janssen; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Takeda
Consulting or Advisory Role - AstraZeneca; BeiGene; DaiichiSankyo; Janssen; Merck Serono; MSD; Novartis; Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); BeiGene (Inst); Blueprint Medicines (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Haihe Biopharma (Inst); Lilly (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Takeda (Inst); Turning Point Therapeutics (Inst)
 
Luis Corrales
Consulting or Advisory Role - AstraZeneca; MSD Oncology; Pfizer; Roche
Speakers' Bureau - AstraZeneca; MSD Oncology; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Pfizer; Roche
 
Karl Redhead
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Ahmadur Rahman
Employment - F. Hoffmann LaRoche
Stock and Other Ownership Interests - Roche
 
Denise Bradley
Employment - Roche
Patents, Royalties, Other Intellectual Property - Roche
 
Elizabeth Theogaraj
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Katherine E. Hutchinson
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Sarah M. Shagan
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Patent author; application filed
 
Benjamin J. Solomon
Honoraria - Amgen (Inst); AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche/Genentech
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; GlaxoSmithKline (Inst); Janssen; Lilly; Merck Sharp & Dohme; Novartis (Inst); Pfizer (Inst); Roche/Genentech; Takeda
Research Funding - Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate